Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Experion to Webcast Live at VirtualInvestorConferences.com
BiotechnologyConferences

Experion to Webcast Live at VirtualInvestorConferences.com

September 9, 2020 8:45 AM

VANCOUVER, BC / ACCESSWIRE / SEPTEMBER 9 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that CEO, Mr. Jarrett Malnarich will present live at VirtualInvestorConferences.com on September 10 at 4:00 PM EDT / 1:00 PM PDT. Experion invites shareholders, investors, advisors and analyst to attend this real-time, interactive presentation. This will be a live, interactive online...

Read more
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
BiotechnologyConferences

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 9, 2020 8:35 AM

Live video webcast with CEO, Jeffrey Eisenberg, on Wednesday, September 16th at 12:00 PM EDT FRAMINGHAM, MA / ACCESSWIRE / September 9, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of...

Read more
Yulong Intends to Develop a Cell Biologics Incubator Lab
BiotechnologyCompany Update

Yulong Intends to Develop a Cell Biologics Incubator Lab

September 9, 2020 8:00 AM

CHEYENNE, WY / ACCESSWIRE / September 9, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it intends to build an incubator laboratory for development of cell and extracellular vesicle (EV) based therapeutics. Our state-of-the-art molecular and cellular biology lab will be equipped for the development of a series of young new cells (naïve) and bioengineered cell lines including mesenchymal stem cells (MSCs) and other...

Read more
BiotechnologyCompany Update

Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

September 9, 2020 7:30 AM

DURHAM, NC / ACCESSWIRE / September 9, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that Jeff Wolf, CEO of Heat Biologics, will participate on a virtual panel, entitled, "New Approaches to COVID-19: Hidden Breakthroughs," being...

Read more
Applied UV, Inc. Subsidiary, SteriLumen, Inc. Enters into Exclusive Distribution Agreement with Akida Holdings LLC, for its Airocide(TM) Air Quality-Improvement(TM) System
BiotechnologyCompany Update

Applied UV, Inc. Subsidiary, SteriLumen, Inc. Enters into Exclusive Distribution Agreement with Akida Holdings LLC, for its Airocide(TM) Air Quality-Improvement(TM) System

September 8, 2020 10:30 AM

SteriLumen Will Become Distributor in the U.S and the Greater Middle East to the Hospitality and Hotel Industry MOUNT VERNON, NY / ACCESSWIRE / September 8, 2020 / Applied UV, Inc. (NASDAQCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and automatically, today announced...

Read more
Havn Life Sciences Announces Completion of Acquisition Transaction
BiotechnologyMergers and Acquisitions

Havn Life Sciences Announces Completion of Acquisition Transaction

September 4, 2020 4:15 PM

VANCOUVER, BC / ACCESSWIRE / September 4, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (the "Company" or "Havn Life"), is pleased to announce that it has successfully completed its acquisition of HAVN Research Inc. ("HAVN Research"), acquiring 100% of the outstanding shares of HAVN Research (the "Acquisition Transaction"). HAVN Research is a biotechnology company engaged in the business of the research and development of psychopharmacological...

Read more
Quanta Announces
BiotechnologyInvestor Relations

Quanta Announces "Town Hall" Style Shareholder Update for September 10, 2020 at 1:30 PM ET

September 4, 2020 9:53 AM

BURBANK, CA / ACCESSWIRE / September 4, 2020 / Quanta, Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual "Town Hall" style investor event, which will be broadcast live over the internet on September 10, 2020 at 1:30 PM ET / 10:30 AM PT. Eric Rice, the company's Chief Executive Officer, will lead...

Read more
Dania Scott Joins Tetra Bio-Pharma as Senior Vice President Commercial Strategy
BiotechnologyCompany Update

Dania Scott Joins Tetra Bio-Pharma as Senior Vice President Commercial Strategy

September 4, 2020 8:00 AM

Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space OTTAWA, ON / ACCESSWIRE / September 4, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is excited to announce that Dania Scott has joined Tetra as the Senior Vice President Commercial Strategy. She will be the lead executive responsible...

Read more
Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences
BiotechnologyConferences

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

September 3, 2020 4:30 PM

BOSTON, MA / ACCESSWIRE / September 3, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences and will provide a corporate update: Baird 2020 Virtual...

Read more
Applied UV Announces Closing of $5,000,000 Initial Public Offering and Closing of $750,000 Overallotment
BiotechnologyCompany Update

Applied UV Announces Closing of $5,000,000 Initial Public Offering and Closing of $750,000 Overallotment

September 3, 2020 1:00 PM

MOUNT VERNON, NY / ACCESSWIRE / September 3, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its initial public offering of 1,000,000 shares of its common stock at a price of $5.00 per share on September 2, 2020 and today's...

Read more
Applied UV Announces Exercise of Over-Allotment Option
BiotechnologyCompany Update

Applied UV Announces Exercise of Over-Allotment Option

September 1, 2020 3:35 PM

MOUNT VERNON, NY / ACCESSWIRE / September 1, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced in connection with its previously announced initial public offering of its common stock, the exercise by Network 1 Financial Securities, Inc., the...

Read more
DSwiss Announces New DNA Testing Business
BiotechnologyInvestor Relations

DSwiss Announces New DNA Testing Business

September 1, 2020 11:25 AM

KUALA LUMPUR, MY / ACCESSWIRE / September 1, 2020 / DSwiss, Inc (OTCPINK:DQWS) today announced that it has ventured into the field of direct-to-consumer DNA Testing. DSwiss has developed an affordable DNA test which gives much insight about yourself, including a personalized and actionable step guide for people to pursue living a healthier and productive life. Our genes play an integral part in determining our health, but our lifestyle...

Read more
Oncocyte to Present at the LD 500 Virtual Conference
BiotechnologyConferences

Oncocyte to Present at the LD 500 Virtual Conference

September 1, 2020 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Oncocyte (NYSE American:OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:20PM PST / 3:20PM EST. Mitch Levine (CFO) and Dr. Doug Ross (CMO) will be presenting to a live virtual...

Read more
Vivos Inc to Present at The LD 500 Virtual Conference
BiotechnologyConferences

Vivos Inc to Present at The LD 500 Virtual Conference

September 1, 2020 9:30 AM

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Vivos Inc (OTCQB:RDGL), a company that has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals and in humans, today announced that it will be presenting at the LD 500 investor conference on Thursday September 3 at 1:40 PST / 4:00 PM EST. Dr. Mike Korenko (CEO of Vivos Inc) will be presenting to a live virtual audience. Register here:...

Read more
Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update
BiotechnologyCompany Update

Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update

August 31, 2020 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / August 31, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced an update on the progress regarding the non-binding term sheet the Company received and previous announced on June 26, 2020 to divest the remaining shares it holds...

Read more
Applied UV Announces Pricing of $5 Million Initial Public Offering
BiotechnologyIPO

Applied UV Announces Pricing of $5 Million Initial Public Offering

August 31, 2020 11:10 AM

MOUNT VERNON, NY / ACCESSWIRE / August 31, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its initial public offering of 1,000,000 shares of its common stock at a price of $5.00 per share. The Company's common stock has been...

Read more
Yulong Recruits Dr. Jason Sanders as CMO
BiotechnologyManagement Changes

Yulong Recruits Dr. Jason Sanders as CMO

August 31, 2020 9:00 AM

CHEYENNE, WY / ACCESSWIRE / August 31, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it has engaged Dr. Jason Sanders as Chief Medical Officer. Dr. Sanders is an expert in the science and medicine of extracellular vesicles (EVs) including exosome-based diagnostic and therapeutic technology. As an honors graduate from Harvard University, Dr. Sanders concentrated in molecular biochemistry, cellular signaling and...

Read more
CEL-SCI Corporation to Present at The LD 500 Virtual Conference
BiotechnologyConferences

CEL-SCI Corporation to Present at The LD 500 Virtual Conference

August 31, 2020 9:00 AM

VIENNA, VA / ACCESSWIRE / August 31, 2020 / CEL-SCI Corporation (NYSE American:CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2nd at 10:20 a.m. ET. Geert Kersten, Chief Executive Officer of CEL-SCI, will be presenting to a live virtual audience. A live audio webcast of the chat will be available at...

Read more
Omnicanna CEO, Greta Gaines with Kelly Carroll from The Fly, Examine the Hempery Brands' Successful Focus on Health and Wellness, the Corona Virus Outbreak and Potential Cannabinoid Solutions, High-Tech Infusions, and Being a Part of the CSi-EDP Economic Development Plan Management Team
BiotechnologyCompany Update

Omnicanna CEO, Greta Gaines with Kelly Carroll from The Fly, Examine the Hempery Brands' Successful Focus on Health and Wellness, the Corona Virus Outbreak and Potential Cannabinoid Solutions, High-Tech Infusions, and Being a Part of the CSi-EDP Economic Development Plan Management Team

August 31, 2020 8:05 AM

RALEIGH, NC / ACCESSWIRE / August 31, 2020 / Omnicanna Health Solutions, Inc. (OTC PINK:ENDO), a U.S. Company specializing in Industrial Hemp Commercialization and Formulation-based health and wellness solutions, is pleased to release Omnicanna CEO Greta Gaines does an interview with Kelly Carroll from The Fly. Greta provides insight to industrial hemp commercialization and her passion to produce 100% natural health and wellness solutions,...

Read more
Yield10 Bioscience to Present at the LD 500 Virtual Conference on September 2, 2020
BiotechnologyConferences

Yield10 Bioscience to Present at the LD 500 Virtual Conference on September 2, 2020

August 27, 2020 9:00 AM

WOBURN, MA / ACCESSWIRE / August 27, 2020 / Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a virtual corporate presentation at the LD 500 Virtual Conference on Wednesday, September 2, 2020 at 1:20 pm ET, Track 2, followed by a live Q&A session with registered investors and other conference attendees. The virtual...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?